Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.

Cellerino M, Cordano C, Boffa G, Bommarito G, Petracca M, Sbragia E, Novi G, Lapucci C, Capello E, Uccelli A, Inglese M.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 12;6(5). pii: e596. doi: 10.1212/NXI.0000000000000596. Print 2019 Sep.

2.

CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS.

Pardini M, Gualco L, Bommarito G, Roccatagliata L, Schiavi S, Solaro C, Mancardi G, Uccelli A, Capello E, Inglese M.

Mult Scler Relat Disord. 2019 Jun;31:93-96. doi: 10.1016/j.msard.2019.03.027. Epub 2019 Apr 2.

PMID:
30953954
3.

Ecological impact of isolated cognitive relapses in MS.

Meli R, Roccatagliata L, Capello E, Bruschi N, Uccelli A, Mancardi G, Inglese M, Pardini M.

Mult Scler. 2018 Nov 15:1352458518813722. doi: 10.1177/1352458518813722. [Epub ahead of print]

PMID:
30430928
4.

Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia.

Lapucci C, Capello E, Romano N, Guolo F, Mavilio N, Roccatagliata L.

Neurol Sci. 2018 Sep;39(9):1637-1639. doi: 10.1007/s10072-018-3435-x. Epub 2018 May 4. No abstract available.

PMID:
29728935
5.

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D.

Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2. Review.

PMID:
29030765
6.

Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia.

Marinelli L, Currà A, Trompetto C, Capello E, Serrati C, Fattapposta F, Pelosin E, Phadke C, Aymard C, Puce L, Molteni F, Abbruzzese G, Bandini F.

J Electromyogr Kinesiol. 2017 Dec;37:84-89. doi: 10.1016/j.jelekin.2017.09.005. Epub 2017 Sep 27.

PMID:
28985544
7.

Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.

Vercellino M, Trebini C, Capello E, Mancardi GL, Giordana MT, Cavalla P.

J Neuroimmunol. 2017 Nov 15;312:49-58. doi: 10.1016/j.jneuroim.2017.09.004. Epub 2017 Sep 8.

PMID:
28919237
8.

Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.

Capodivento G, Visigalli D, Garnero M, Fancellu R, Ferrara MD, Basit A, Hamid Z, Pastore VP, Garibaldi S, Armirotti A, Mancardi G, Serrati C, Capello E, Schenone A, Nobbio L.

Sci Rep. 2017 Aug 10;7(1):7831. doi: 10.1038/s41598-017-08314-1.

9.

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS.

Bommarito G, Bellini A, Pardini M, Solaro C, Roccatagliata L, Laroni A, Capello E, Mancardi GL, Uccelli A, Inglese M.

Mult Scler. 2018 Apr;24(5):623-631. doi: 10.1177/1352458517704077. Epub 2017 Apr 10.

PMID:
28394195
10.

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Ferraro D, Franciotta D, Bedin R, Solaro C, Cocco E, Santangelo M, Immovilli P, Gajofatto A, Calabrese M, Di Filippo M, Orlandi R, Simone AM, Vitetta F, Capello E, Giunti D, Murialdo A, Frau J, Mariotto S, Gallina A, Gasperini C, Sola P; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

J Neurol. 2017 May;264(5):973-978. doi: 10.1007/s00415-017-8480-5. Epub 2017 Apr 5.

PMID:
28382419
11.

The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.

Marinelli L, Mori L, Canneva S, Colombano F, Currà A, Fattapposta F, Bandini F, Capello E, Abbruzzese G, Trompetto C.

Int Clin Psychopharmacol. 2016 Jul;31(4):232-9. doi: 10.1097/YIC.0000000000000126.

PMID:
27003093
12.

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.

Kruse N, Persson S, Alcolea D, Bahl JM, Baldeiras I, Capello E, Chiasserini D, Bocchio Chiavetto L, Emersic A, Engelborghs S, Eren E, Fladby T, Frisoni G, García-Ayllón MS, Genc S, Gkatzima O, Heegaard NH, Janeiro AM, Kováčech B, Kuiperij HB, Leitão MJ, Lleó A, Martins M, Matos M, Mollergard HM, Nobili F, Öhrfelt A, Parnetti L, de Oliveira CR, Rot U, Sáez-Valero J, Struyfs H, Tanassi JT, Taylor P, Tsolaki M, Vanmechelen E, Verbeek MM, Zilka N, Blennow K, Zetterberg H, Mollenhauer B.

Neurobiol Aging. 2015 Sep;36(9):2587-96. doi: 10.1016/j.neurobiolaging.2015.05.003. Epub 2015 May 15.

PMID:
26093515
13.

Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.

Curro' D, Vuolo L, Gualandi F, Bacigalupo A, Roccatagliata L, Capello E, Uccelli A, Saccardi R, Sormani MP, Mancardi G.

Mult Scler. 2015 Oct;21(11):1423-30. doi: 10.1177/1352458514564484. Epub 2015 Jan 12.

PMID:
25583838
14.

Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine.

Alicino C, Infante MT, Gandoglia I, Miolo N, Mancardi GL, Zappettini S, Capello E, Orsi A, Tamburini T, Grandis M.

Hum Vaccin Immunother. 2014;10(7):1969-73. doi: 10.4161/hv.28961.

15.

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.

Laroni A, Gandoglia I, Solaro C, Ribizzi G, Tassinari T, Pizzorno M, Parodi S, Baldassarre G, Rilla MT, Venturi S, Capello E, Sormani MP, Uccelli A, Mancardi GL.

BMC Neurol. 2014 May 12;14:103. doi: 10.1186/1471-2377-14-103.

16.

A comprehensive robust adaptive controller for gust load alleviation.

Capello E, Guglieri G, Quagliotti F.

ScientificWorldJournal. 2014 Feb 4;2014:609027. doi: 10.1155/2014/609027. eCollection 2014.

17.

Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.

Guaschino C, Esposito F, Liberatore G, Colombo B, Annovazzi P, D'Amico E, Cavalla P, Capello E, Capra R, Galimberti D, Tedeschi G, Grimaldi L; PROGRESSO Group; PROGEMUS Group, Leone M, D'Alfonso S, Martinelli V, Comi G, Martinelli-Boneschi F.

Neurol Sci. 2014 May;35(5):789-91. doi: 10.1007/s10072-014-1650-7. Epub 2014 Feb 11.

PMID:
24514917
18.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Trojano M, Zaffaroni M, Malucchi S; Italian Multiple Sclerosis Study group.

Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29. Erratum in: Neurol Sci. 2014 Oct;35(10):1645-6. Troiano, Maria [corrected to Trojano, Maria].

PMID:
24374787
19.

Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders.

Racca F, Mongini T, Wolfler A, Vianello A, Cutrera R, Del Sorbo L, Capello EC, Gregoretti C, Massa R, De Luca D, Conti G, Tegazzin V, Toscano A, Ranieri VM.

Minerva Anestesiol. 2013 Apr;79(4):419-33. Epub 2013 Feb 18. Review.

PMID:
23419334
20.

Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.

Ghezzi A, Annovazzi P, Amato MP, Capello E, Cavalla P, Cocco E, Falcini M, Gallo A, Patti F, Perini P, Rodegher ME, Rovaris M, Rottoli MR, Comi G; MS Study Group-Italian Society of Neurology.

Mult Scler. 2013 Jun;19(7):961-3. doi: 10.1177/1352458513475491. Epub 2013 Feb 4. Erratum in: Mult Scler. 2014 May;20(6):768.

PMID:
23380649
21.

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.

Ghezzi A, Annovazzi P, Cocco E, Coarelli G, Lugaresi A, Rovaris M, Patti F, Capello E, Rodegher ME, Moiola L, Malucchi S, Salemi G, De Rossi N, Provinciali L, Perini P, Bergamaschi R, Scarpini E, Lus G, Gallo A, Tola MR, Amato MP, Rottoli MR, Bianchi A, Comi G; MS Study Group-Italian Society of Neurology.

Neurol Sci. 2013 Sep;34(9):1633-7. doi: 10.1007/s10072-013-1300-5. Epub 2013 Jan 25.

PMID:
23354606
22.

Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion.

Lucatello B, Benso A, Tabaro I, Capello E, Caprino MP, Marafetti L, Rossato D, Oleandri SE, Ghigo E, Maccario M.

Eur J Endocrinol. 2013 Mar 15;168(4):525-32. doi: 10.1530/EJE-12-0912. Print 2013 Apr.

23.

Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients.

Reale M, de Angelis F, di Nicola M, Capello E, di Ioia M, Luca Gd, Lugaresi A, Tata AM.

Int J Mol Sci. 2012 Oct 3;13(10):12656-64. doi: 10.3390/ijms131012656.

24.

Reward responsiveness and fatigue in multiple sclerosis.

Pardini M, Capello E, Krueger F, Mancardi G, Uccelli A.

Mult Scler. 2013 Feb;19(2):233-40. doi: 10.1177/1352458512451509. Epub 2012 Jun 21.

PMID:
22723570
25.

Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification.

Laroni A, Giacomazzi CG, Grimaldi L, Gallo P, Sormani MP, Bertolotto A, McDermott JL, Gandoglia I, Martini I, Vitello G, Rinaldi F, Barzon L, Militello V, Pizzorno M, Bandini F, Capello E, Palù G, Uccelli A, Mancardi GL, Varnier OE.

J Neuroimmune Pharmacol. 2012 Sep;7(3):665-72. doi: 10.1007/s11481-012-9366-z. Epub 2012 May 16.

PMID:
22585413
26.

Neuromuscular patients as candidates for non invasive ventilation during the weaning process.

Racca F, Del Sorbo L, Capello EC, Ranieri VM.

Minerva Anestesiol. 2012 Mar;78(3):391. No abstract available.

27.

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.

Mancardi GL, Sormani MP, Di Gioia M, Vuolo L, Gualandi F, Amato MP, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola MR, Scarpini E, Repice AM, Massacesi L, Saccardi R; Italian BMT Study Group.

Mult Scler. 2012 Jun;18(6):835-42. doi: 10.1177/1352458511429320. Epub 2011 Nov 29.

PMID:
22127896
28.

Invasive and non-invasive long-term mechanical ventilation in Italian children.

Racca F, Bonati M, Del Sorbo L, Berta G, Sequi M, Capello EC, Wolfler A, Salvo I, Bignamini E, Ottonello G, Cutrera R, Biban P, Benini F, Ranieri VM.

Minerva Anestesiol. 2011 Sep;77(9):892-901.

29.

Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.

Vercellino M, Grifoni S, Romagnolo A, Masera S, Mattioda A, Trebini C, Chiavazza C, Caligiana L, Capello E, Mancardi GL, Giobbe D, Mutani R, Giordana MT, Cavalla P.

Mult Scler. 2011 Oct;17(10):1194-201. doi: 10.1177/1352458511406164. Epub 2011 May 25.

30.

Long-term home ventilation of children in Italy: a national survey.

Racca F, Berta G, Sequi M, Bignamini E, Capello E, Cutrera R, Ottonello G, Ranieri VM, Salvo I, Testa R, Wolfler A, Bonati M; LTV Pediatric Italian Network.

Pediatr Pulmonol. 2011 Jun;46(6):566-72. doi: 10.1002/ppul.21401. Epub 2010 Dec 30.

PMID:
21560263
31.

Association of melanoma and natalizumab therapy in the Italian MS population: a second case report.

Laroni A, Bedognetti M, Uccelli A, Capello E, Mancardi GL.

Neurol Sci. 2011 Feb;32(1):181-2. doi: 10.1007/s10072-010-0427-x. Epub 2010 Nov 5.

PMID:
21052756
32.

Clinical features of Sjogren's syndrome in patients with multiple sclerosis.

Annunziata P, De Santi L, Di Rezze S, Millefiorini E, Capello E, Mancardi G, De Riz M, Scarpini E, Vecchio R, Patti F.

Acta Neurol Scand. 2011 Aug;124(2):109-14. doi: 10.1111/j.1600-0404.2010.01428.x. Epub 2010 Aug 31.

PMID:
20809902
33.

Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.

Scalabrino G, Galimberti D, Mutti E, Scalabrini D, Veber D, De Riz M, Bamonti F, Capello E, Mancardi GL, Scarpini E.

Brain Res. 2010 May 28;1333:64-71. doi: 10.1016/j.brainres.2010.03.073. Epub 2010 Mar 27.

PMID:
20347721
34.

A case of secondary syphilis presenting as optic neuritis.

Bandettini di Poggio M, Primavera A, Capello E, Bandini F, Mazzarello G, Viscoli C, Schenone A.

Neurol Sci. 2010 Jun;31(3):365-7. doi: 10.1007/s10072-010-0222-8. Epub 2010 Feb 25.

PMID:
20182899
35.

Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks.

Capello E, Vuolo L, Gualandi F, Van Lint MT, Roccatagliata L, Bonzano L, Pardini M, Uccelli A, Mancardi G.

Neurol Sci. 2009 Oct;30 Suppl 2:S175-7. doi: 10.1007/s10072-009-0144-5. Review.

PMID:
19882370
36.

Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.

J Neuropathol Exp Neurol. 2009 May;68(5):489-502. doi: 10.1097/NEN.0b013e3181a19a5a.

PMID:
19525897
37.

Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study.

Vercellino M, Votta B, Condello C, Piacentino C, Romagnolo A, Merola A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.

J Neuroimmunol. 2008 Aug 13;199(1-2):133-41. doi: 10.1016/j.jneuroim.2008.04.035. Epub 2008 Jun 9.

PMID:
18539342
38.

Carcinoma of the tongue mimicking bulbar amyotrophic lateral sclerosis.

Bandettini di Poggio M, Brogi D, Leonardi A, Pizzorno M, Schenone G, Mancardi GL, Capello E, Schenone A.

Neurol Sci. 2008 Apr;29(2):127. doi: 10.1007/s10072-008-0874-9. No abstract available.

PMID:
18483713
39.

Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.

Solaro C, Brichetto G, Capello E, Abuarqub S, Sanguineti V.

Eur J Neurol. 2008 Jun;15(6):619-26. doi: 10.1111/j.1468-1331.2008.02129.x.

PMID:
18474077
40.

Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience.

Gualandi F, Bruno B, Van Lint MT, Luchetti S, Uccelli A, Capello E, Mancardi GL, Bacigalupo A, Marmont A.

Ann N Y Acad Sci. 2007 Sep;1110:455-64.

PMID:
17911461
41.

Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.

Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.

J Neuropathol Exp Neurol. 2007 Aug;66(8):732-9.

PMID:
17882017
42.

Granulocytic sarcoma: an unusual cause of spinal cord compression.

Balleari E, Panarello S, Capello E, Grosso M, Passalia C, Pitto P, Raggi F, Roccatagliata L, Cabiddu F, Ghio R.

Int J Clin Oncol. 2007 Jun;12(3):234-7. Epub 2007 Jun 27. Review.

PMID:
17566850
43.

Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells.

Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F.

J Neuropathol Exp Neurol. 2006 Feb;65(2):124-41.

PMID:
16462204
44.

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.

Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL; Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis.

Neurol Sci. 2005 Dec;26 Suppl 4:S200-3.

PMID:
16388358
45.

B-cell differentiation in the CNS of patients with multiple sclerosis.

Corcione A, Aloisi F, Serafini B, Capello E, Mancardi GL, Pistoia V, Uccelli A.

Autoimmun Rev. 2005 Nov;4(8):549-54. Review.

PMID:
16214094
46.

Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination.

Franciotta D, Avolio C, Capello E, Lolli F; AINI.

J Neurol Sci. 2005 Oct 15;237(1-2):5-11. Review.

PMID:
16111707
47.

Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis.

Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A, Ciceri F, Schenone A, Parodi RC, Capello E, Comi G, Uccelli A.

Mult Scler. 2005 Jun;11(3):367-71.

PMID:
15957523
48.

Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis.

Capello E, Mancardi GL.

Neurol Sci. 2004 Nov;25 Suppl 4:S361-3. Review.

PMID:
15727234
49.

The 14-3-3 protein in multiple sclerosis: a marker of disease severity.

Colucci M, Roccatagliata L, Capello E, Narciso E, Latronico N, Tabaton M, Mancardi GL.

Mult Scler. 2004 Oct;10(5):477-81.

PMID:
15471360
50.

Progressive multifocal leukoencephalopathy in an adult patient with ICF syndrome.

Colucci M, Cocito L, Capello E, Mancardi GL, Serrati C, Cinque P, Schenone A.

J Neurol Sci. 2004 Jan 15;217(1):107-10.

PMID:
14675617

Supplemental Content

Loading ...
Support Center